Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/23/2887708/0/en/Sensei-Biotherapeutics-Presents-Promising-Clinical-Data-from-Phase-1-Dose-Escalation-Study-of-SNS-101.html
https://www.globenewswire.com/news-release/2024/05/09/2878649/0/en/Sensei-Biotherapeutics-Reports-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/04/24/2869061/0/en/Sensei-Biotherapeutics-to-Present-Topline-Clinical-Data-from-the-SNS-101-Phase-I-Dose-Escalation-Study-at-the-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/09/2859874/0/en/Sensei-Biotherapeutics-to-Participate-in-Canaccord-Genuity-s-Horizons-in-Oncology-Virtual-Conference.html
https://www.globenewswire.com/news-release/2024/04/04/2858193/0/en/Sensei-Biotherapeutics-Announces-Nature-Communications-Publication-Describing-Mechanism-of-Action-of-SNS-101-Selectively-Targeting-the-Active-Form-of-VISTA-within-the-Tumor-Microen.html
https://www.globenewswire.com/news-release/2024/03/22/2850889/0/en/Sensei-Biotherapeutics-to-Participate-in-the-3rd-Annual-VISTA-Symposium.html
https://www.globenewswire.com//news-release/2024/03/06/2841294/0/en/Sensei-Biotherapeutics-to-Present-New-Preclinical-Data-at-Upcoming-Scientific-Conferences.html
https://www.globenewswire.com//news-release/2024/02/28/2836858/0/en/Sensei-Biotherapeutics-Reports-Full-Year-2023-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com//news-release/2024/02/07/2825076/0/en/Sensei-Biotherapeutics-to-Present-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2024/01/04/2803878/0/en/Sensei-Biotherapeutics-Provides-Corporate-Update-and-Highlights-Key-Upcoming-Milestones.html